EVEREST ORGANICS
|
The Current P/E Ratio of EVEREST ORGANICS is 55.32.
| Share Price | ₹332.4 | Feb 16,2026 |
| Market Cap | ₹322.4 Cr | |
| Earnings-TTM | ₹5.8 Cr | TTM-Standalone Results |
| Price/Earnings | 55.32x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of EVEREST ORGANICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹322.4 Cr] as on Feb 16,2026
(/) Earnings [ ₹5.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 55.32x ]
Thus, for EVEREST ORGANICS , the investors are currently willing to pay 55.32 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of EVEREST ORGANICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of EVEREST ORGANICS over the last five years.
Historical PE (Price/Earnings) ratio chart of EVEREST ORGANICS
PE Ratio Performance Analysis for EVEREST ORGANICS
- EVEREST ORGANICS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 158.95x.
- EVEREST ORGANICS 's operated at median p/e ratio of 13.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, EVEREST ORGANICS 's p/e ratio peaked in Mar2024 at 659.77x.
- EVEREST ORGANICS 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does EVEREST ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| EVEREST ORGANICS | 5.83 | 55.32 | 322.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.07 | 407,827.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 65.90 | 163,363.0 |
| CIPLA LTD | 4,544.70 | 24.10 | 109,519.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.47 | 144,193.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.23 | 105,940.0 |
| MANKIND PHARMA LTD | 1,796.65 | 47.84 | 85,946.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.56 | 91,567.3 |
| LUPIN LTD | 4,669.18 | 21.74 | 101,486.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 19.59 | 68,819.2 |
| ABBOTT INDIA LTD | 1,524.13 | 36.70 | 55,934.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs EVEREST ORGANICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.56x |
| Max industry PE | 65.90x |
| Median industry PE | 36.70x |
| Average industry PE | 37.23x |
You may also like the below Video Courses